Free tool
Stocks listed on B3 São Paulo
We cover 33 companies listed on B3 São Paulo. The median market value in the group is $46.72B. Across the group, the median move over the past trading day is 0.00%. 59% of the 32 with a 200-day average trade above it. Price change over the past year runs from −24.2% to +51.5% across the middle 80 percent of the group, with a median of +7.8%.
Other lists in this group
Table
33 of 2,037 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| LILY34.SA | Eli Lilly and Company | $1.10T | Mega cap | +59.83% |
| JNJB34.SA | Johnson & Johnson | $658.09B | Mega cap | +47.82% |
| ABBV34.SA | AbbVie Inc. | $467.00B | Mega cap | +21.88% |
| N1VS34.SA | Novartis AG | $301.83B | Mega cap | +20.04% |
| A1ZN34.SA | AstraZeneca PLC | $258.63B | Mega cap | +0.13% |
| N1VO34.SA | Novo Nordisk A/S | $208.90B | Mega cap | −17.86% |
| ABTT34.SA | Abbott Laboratories | $199.23B | Large cap | −16.35% |
| DHER34.SA | Danaher Corporation | $151.72B | Large cap | +0.89% |
| I1SR34.SA | Intuitive Surgical, Inc. | $132.60B | Large cap | −25.36% |
| S1YK34.SA | Stryker Corporation | $126.60B | Large cap | −19.51% |
| G1SK34.SA | GSK plc | $104.64B | Large cap | +27.31% |
| E1LV34.SA | Elevance Health, Inc. | $86.53B | Large cap | +21.66% |
| REGN34.SA | Regeneron Pharmaceuticals, Inc. | $85.16B | Large cap | +33.80% |
| M1RN34.SA | Moderna, Inc. | $63.51B | Large cap | +462.13% |
| C1AH34.SA | Cardinal Health, Inc. | $55.77B | Large cap | +52.41% |
| E1WL34.SA | Edwards Lifesciences Corporation | $47.29B | Large cap | −4.72% |
| H1UM34.SA | Humana Inc. | $46.72B | Large cap | +24.36% |
| I1DX34.SA | IDEXX Laboratories, Inc. | $44.35B | Large cap | −17.31% |
| D1EX34.SA | DexCom, Inc. | $33.75B | Large cap | +9.64% |
| C1NC34.SA | Centene Corporation | $32.65B | Large cap | +116.61% |
| Z1TS34.SA | Zoetis Inc. | $32.03B | Large cap | −52.31% |
| A1LN34.SA | Alnylam Pharmaceuticals, Inc. | $31.78B | Large cap | −49.35% |
| RDOR3.SA | Rede D'Or São Luiz S.A. | $14.92B | Large cap | +1.37% |
| B1AX34.SA | Baxter International Inc. | $13.60B | Large cap | +3.61% |
| R1VT34.SA | Revvity, Inc. | $12.50B | Large cap | +22.81% |
| DVAI34.SA | DaVita Inc. | $11.70B | Large cap | +18.80% |
| A1LG34.SA | Align Technology, Inc. | $11.51B | Large cap | +7.83% |
| I1QV34.SA | IQVIA Holdings Inc. | $10.82B | Large cap | −67.19% |
| E2XE34.SA | Exelixis, Inc. | $6.61B | Mid cap | +23.92% |
| RADL3.SA | Raia Drogasil S.A. | $6.56B | Mid cap | +7.42% |
| T1FX34.SA | Teleflex Incorporated | $6.00B | Mid cap | +0.29% |
| HYPE3.SA | Hypera S.A. | $2.98B | Mid cap | −4.69% |
| CLOV34.SA | Clover Health Investments, Corp. | $2.15B | Mid cap | +45.23% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.